Mechanisms and management of antibiotic-associated diarrhea

Clinical Infectious Diseases

Volumn 27, Issue 4, 1998, Pages 702-710

  Högenauer, Christoph ^a   Hammer, Heinz F ^a   Krejs, Guenter J ^a   Reisinger, Emil C ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BILE ACID; CARBOHYDRATE; ERYTHROMYCIN; NEOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL OVERGROWTH; BILE ACID METABOLISM; CANDIDA; CARBOHYDRATE METABOLISM; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM PERFRINGENS; DIARRHEA; HUMAN; INTESTINE FLORA; KLEBSIELLA OXYTOCA; PRIORITY JOURNAL; SALMONELLA; STAPHYLOCOCCUS AUREUS;

EID: 2442731097     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/514958     Document Type: Article

References (90)

1. Hammer HF, Fine KD, Santa Ana CA, Porter JL, Schiller LR, Fordtran JS. Carbohydrate malabsorption: its measurement and its contribution to diarrhea. J Clin Invest 1990; 86:1936-44.
2. Katz DA, Lynch ME, Littenberg B. Clinical prediction rules to optimize cytotoxin testing for Clostridium difficile in hospitalized patients with diarrhea. Am J Med 1996; 100:487-95.
3. Fekety R. Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. Am J Gastroenterol 1997; 92: 739-50.
4. Bartlett JG. Management of Clostridium difficile infection and other antibiotic-associated diarrhoeas. Eur J Gastroenterol Hepatol 1996; 8:1054-61.
5. Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Engl J Med 1994; 330:257-62.
6. Bartlett JG. Antibiotic-associated diarrhea. Clin Infect Dis 1992; 15:573-81.
7. Pothoulakis C. Pathogenesis of Clostridium difficile-associated diarrhoea. Eur J Gastroenterol Hepatol 1996; 8:1041-7.
8. Yamamoto-Osaki T, Kamiya S, Sawamura S, Kai M, Ozawa A. Growth inhibition of Clostridium difficile by intestinal flora of infant faeces in continuous flow culture. J Med Microbiol 1994; 40:179-87.
9. Goldhill JM, Rose K, Percy WH. Effects of antibiotics on epithelial ion transport in the rabbit distal colon in-vitro. J Pharm Pharmacol 1996; 48:651-6.
10. Riegler M, Sedivy R, Pothoulakis C, et al. Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro. J Clin Invest 1995; 95:2004-11.
11. McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989; 320:204-10.
12. Larson HE, Barclay FE, Honour P, Hill ID. Epidemiology of Clostridium difficile in infants. J Infect Dis 1982; 146:727-33.
13. Libby JM, Donta ST, Wilkins TD. Clostridium difficile toxin A in infants. J Infect Dis 1983; 148:606.
14. Cheng SH, Lu JJ, Young TG, Perng CL, Chi WM. Clostridium difficile-associated diseases: comparison of symptomatic infection versus carriage on the basis of risk factors, toxin production, and genoryping results. Clin Infect Dis 1997; 25:157-8.
15. Nolan NP, Kelly CP, Humphreys JF, et al. An epidemic of pseudomembranous colitis: importance of person to person spread. Gut 1987; 28:1467-73.
16. Bender BS, Bennett R, Laughon BE, et al. Is Clostridium difficile endemic in chronic-care facilities? Lancet 1986; 2:11-3.
17. Borriello SP, Larson HE, Welch AR, Barclay F. Enterotoxigenic Clostridium perfringens: a possible cause of antibiotic-associated diarrhoea. Lancet 1984; 1:305-7.
18. Larson HE, Borriello SP. Infectious diarrhea due to Clostridium perfringens. J Infect Dis 1988; 157:390-1.
19. Borriello SP, Barclay FE, Welch AR, et al. Epidemiology of diarrhoea caused by enterotoxigenic Clostridium perfringens. J Med Microbiol 1985; 20:363-72.
20. Borriello SP. Clostridial disease of the gut. Clin Infect Dis 1995; 20(suppl 2):S242-50.
21. McDonald M, Ward P, Harvey K. Antibiotic-associated diarrhoea and methicillin-resistant Staphylococcus aureus. Med J Aust 1982; 1: 462-4.
22. Inamatsu T, Ooshima H, Fukayama M, Masuda Y, Hatakeyama T. Clinical spectrum of antibiotic associated enterocolitis due to methicillin resistant Staphylococcus aureus. Nippon Rinsho 1992; 50:1087-92.
23. Hori K, Yura J, Shinagawa N, Sakurai S, Mashita K, Mizuno A. Postoperative enterocolitis and current status of MRSA enterocolitis - the result of a questionnaire survey in Japan. Kansenshogaku Zasshi 1989; 63: 701-7.
24. Scopetti F, Orefici G, Biondi F, Benini F. Staphylococcus aureus resistant to methicillin and gentamicin as a cause of outbreak of epidemic enteritis in a hospital. Boll Ist Sieroter Milan 1983; 62:406-11.
25. Taylor M, Ajayi F, Almond M. Enterocolitis caused by methicillin-resistant Staphylococcus aureus. Lancet 1993; 342:804.
26. Toffler RB, Pingoud EG, Burrell MI. Acute colitis related to penicillin and penicillin-derivatives. Lancet 1978; 2:707-9.
27. Mrowka C, Muench R, Rezzonico M, Greminger P. Acute segmental hemorrhagic penicillin-associated colitis. Dtsch Med Wochenschr 1990; 115:1750-3.
28. Flueckiger T, Froehli P, Baltisser I. Antibiotic-associated segmental hemorrhagic colitis: a case report. Z Gastroenterol 1992; 30:262-3.
29. Benz C, Kohler B, Riemann JF. Acute segmental hemorrhagic penicillin-associated colitis in a 32-year-old patient. Leber Magen Darm 1994; 24:171-3.
30. Minami J, Katayama S, Matsushita O, Sakamoto H, Okabe A. Enterotoxic activity of Klebsiella oxytoca cytotoxin in rabbit intestinal loops. Infect Immun 1994; 62:172-7.
31. Cleau D, Humblot S, Jobard JM, Berger M. Acute right side hemorrhagic colitis with demonstration of Klebsiella oxytoca after treatment with amoxicillin. Presse Med 1994; 23:1879-80.
32. Grando V, Bellaiche G, Le Pennec MP, et al. Ulcerative hemorrhagic proctitis caused by Klebsiella oxytoca after treatment with an amoxicillin-clavulanic acid combination. Gastroenterol Clin Biol 1994; 18:536-7.
33. Benoit R, Dorval D, Loulergue J, et al. Post-antibiotic diarrheas: role of Klebsiella oxytoca. Gastroenterol Clin Biol 1992; 16:860-4.
34. Farmer JJ. Enterobacteriaceae. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology. 6th ed. Washington, DC: ASM Press, 1995.
35. Chida T, Nakaya R, Tsuji M, et al. Intestinal microflora of patients with antibiotic-associated hemorrhagic colitis associated with Klebsiella oxytoca and Clostridium difficile enterotoxin. Kansenshogaku Zasshi 1986; 60:608-15.
36. Holmberg SD, Osterholm MT, Senger KA, Cohen ML. Drug-resistant Salmonella from animal fed antimicrobials. N Engl J Med 1984; 311: 617-22.
37. Danna PL, Urban C, Bellin E, Rahal JJ. Role of Candida in pathogenesis of antibiotic-associated diarrhoea in elderly inpatients. Lancet 1991; 337:511-4.
38. Ponnuvel KM, Rajkumar R, Menon T, Sankaranarayanan VS. Role of Candida in indirect pathogenesis of antibiotic associated diarrhoea in infants. Mycopathologia 1996; 135:145-7.
39. Sanderson PJ, Bukhari SS. Candida spp. and Clostridium difficile toxin-negative antibiotic-associated diarrhoea. J Hosp Infect 1991; 19: 142-3.
40. Gupta TP, Ehrinpreis MN. Candida-associated diarrhea in hospitalized patients. Gastroenterology 1990; 98:780-5.
41. Odds FC. Pathogenesis of candidosis: toxins. In: Odds FC, ed. Candida and candidosis: a review and bibliography. 2nd ed. Vol. 1. London: Bailliere-Tindell, 1988:264-6.
42. Levine J, Dykoski RK, Janoff EN. Candida-associated diarrhea: a syndrome in search of credibility. Clin Infect Dis 1995; 21:881-6.
43. Eras P, Goldstein MJ, Sherlock P. Candida infection in the gastrointestinal tract. Medicine 1972; 51:367-79.
44. Prescott RJ, Harris M, Banerjee SS. Fungal infections of the small and large intestine. J Clin Pathol 1992; 45:806-11.
45. Micozzi A, Cartoni C, Monaco M, Martino P, Zittoun R, Mandelli F. High incidence of infectious gastrointestinal complications observed in patients with acute myeloid leukemia receiving intensive chemotherapy for first induction of remission. Support Care Cancer 1996; 4:294-7.
46. Besnard M, Hartmann O, Valteau-Couanet D, Robert MC, Brugieres L, Lemerle J. Systemic candida infection in pediatric BM autotransplantation: clinical signs, outcome, and prognosis. Bone Marrow Transplant 1993; 11:465-70.
47. Smith CJ, Bryant MP. Introduction to metabolic activities of intestinal bacteria. Am J Clin Nutr 1979; 32:149-57.
48. Ruppin H, Bar-Meir S, Soergel KH, Wood CM, Schmitt MG Jr. Absorption of short-chain fatty acids by the colon. Gastroenterology 1980; 78:1500-7.
49. Hammer HF, Santa Ana CA, Schiller LR, Fordtran JS. Studies of osmotic diarrhea induced in normal subjects by ingestion of polyethylene glycol and lactulose. J Clin Invest 1989; 84:1056-62.
50. Roediger WE. Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut 1980; 21:793-8.
51. Roediger WE. The colonic epithelium in ulcerative colitis: an energy-deficiency disease? Lancet 1980; 2:712-5.
52. Harig JM, Soergel KH, Komorowski RA, Wood CM. Treatment of diversion colitis with short-chain fatty acid irrigation. N Engl J Med 1989; 320:23-8.
53. Edwards CA, Duerden BI, Read NW. Effect of clindamycin on the ability of a continuous culture of colonic bacteria to ferment carbohydrate. Gut 1986; 27:411-7.
54. Rao SS, Edwards CA, Austen CJ, Bruce C, Read NW. Impaired colonic fermentation of carbohydrate after ampicillin. Gastroenterology 1988; 94:928-32.
55. Finegold SM. Interaction of antimicrobial therapy and intestinal flora. Am J Clin Nutr 1970; 23:1466-71.
56. Kurpad AV, Shetty PS. Effects of antimicrobial therapy on faecal bulking. Gut 1986; 27:55-8.
57. Bjorneklett A, Midtvedt T. Influence of three antimicrobial agents - penicillin, metronidazole and doxycyclin - on the intestinal microflora of healthy humans. Scand J Gastroenterol 1981; 16:473-80.
58. Clausen MR, Bonnen H, Tvede M, Brobech-Mortensen P. Colonic fermentation to short-chain fatty acids is decreased in antibiotic-associated diarrhea. Gastroenterology 1991; 101:1497-504.
59. Hove H, Tvede M, Brobech-Mortensen P. Antibiotic-associated diarrhoea, Clostridium difficile, and short-chain fatty acids. Scand J Gastroenterol 1996; 31:688-93.
60. Hammer J, Pruckmayer M, Bergmann H, Kletter K, Gangl A. The distal colon provides reserve storage capacity during colonic fluid overload. Gut 1997; 41:658-63.
61. Hofmann AF. Bile acids, diarrhea and antibiotics: data, speculation, and a unifying hypothesis. J Infect Dis 1977; 135(suppl):S126-32.
62. McJunkin B, Fromm H, Sarva RP, Amin P. Factors in the mechanism of diarrhea in bile acid malabsorption: fecal pH - a key determinant. Gastroenterology 1981; 80:1454-64.
63. Takamine F, Imamura T. Isolation and characterization of bile acid 7-dehydroxylating bacteria from human feces. Microbiol Immunol 1995; 39:11-8.
64. Berr F, Kullak-Ublick GA, Paumgartner G, Münzing W, Hylemon PB. 7α-Dehydroxylating bacteria enhance deoxycholic acid input and cholesterol saturation of bile in patients with gallstones. Gastroenterology 1996; 111:1611-20.
65. Peeters TL, Matthijs G, Depoortere I, Cachet T, Hoogmartens J, Vantrappen G. Erythromycin is a motilin receptor agonist. Am J Physiol 1989; 257:G470-4.
66. Petnehazy T, Scheidl S, Gasser R, Holzer P, Krejs GJ, Hammer HF. Erythromycin inhibits peristaltic motility in guinea pig ileum. Gastroenterology 1997; 112:A805.
67. Itoh Z, Nakaya M, Suzuki T, et al. Erythromycin mimics exogenous motilin in gastrointestinal contractile activity in the dog. Am J Physiol 1984; 247:G688-94.
68. Otterson MF, Sarna SK. Gastrointestinal motor effects of erythromycin. Am J Physiol 1990; 259:G355-63.
69. Peeters TL. Erythromycin and other macrolides as prokinetic agents. Gastroenterology 1993; 105:1886-99.
70. Charles F, Phillips SF, Camilleri M, Thomforde GM. Rapid gastric emptying in patients with functional diarrhea. Mayo Clin Proc 1997; 72:323-8.
71. Caron F, Ducrotte P, Lerebours E, Colin R, Humbert G, Denis P. Effects of amoxicillin clavulanate combination on the motility of the small intestine in human beings. Antimicrob Agents Chemother 1991; 35: 1085-8.
72. Lees GM, Percy WH. Antibiotic-associated colitis: an in-vitro investigation of the effects of antibiotics on intestinal motility. Br J Pharmacol 1981; 73:535-47.
73. Percy WH, Christensen J. Antibiotic depression of evoked and spontaneous responses of opossum distal colonic muscularis mucosae in-vivo: a factor in antibiotic-associated colitis? Gastroenterology 1985; 88:964-70.
74. Dobbins WO, Herrero BA, Mansbach CM. Morphologic alterations associated with neomycin induced malabsorption. Am J Med Sci 1968; 225: 63-77.
75. Staneck JL, Weckbach LS, Allen SD, et al. Multicenter evaluation of four test methods for Clostridium difficile detection: Immuno Card C. difficile, cytotoxin assay, culture and latex agglutination. J Clin Microbiol 1996; 34:2718-21.
76. Rolfe RD, Finegold SM. Purification and characterization of Clostridium difficile toxin. Infect Immun 1979; 25:191-201.
77. Sullivan NM, Pellet S, Wilkins TD. Purification and characterization of toxins A and B of Clostridium difficile. Infect Immun 1982; 35:1032-40.
78. Tedesco FJ, Coreless JK, Brownstein RE. Rectal sparing in antibiotic-associated pseudomembranous colitis: a prospective study. Gastroenterology 1982; 83:1259-60.
79. Reinke CM, Messick CR. Update on Clostridium difficile-induced colitis. Am J Hosp Pharm 1994; 51:1771-81.
80. Trevisani F, Simoncini M, Alampi G, Bernardi M. Colitis associated to chemotherapy with 5-fluorouracil. Hepatogastroenterology 1997; 44: 710-2.
81. Anand A, Bashey B, Mir T, Glatt AE. Epidemiology, clinical manifestations, and outcome of Clostridium difficile-associated diarrhea. Am J Gastroenterol 1994; 89:519-23.
82. Fleming SE, Marthinsen D, Kuhnlein H. Colonic function and fermentation in men consuming high fiber diets. J Nutr 1983; 113:2535-44.
83. Surawicz CM, Elmer GW, Speelman P, McFarland LV, Chinn J, van Belle G. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology 1989; 96:981-8.
84. Wunderlich PF, Braun L, Fumagalli I, et al. Double-blind report of the efficacy of lactic acid-producing Enterococcus SF68 in the prevention of antibiotic-associated diarrhoea and in the treatment of acute diarrhoea. J Int Med Res 1989; 17:333-8.
85. Wenisch C, Parschalk B, Hasenhundl M, Hirschl AM, Graninger W. Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea. Clin Infect Dis 1996; 22:813-8.
86. Cronberg S, Castor B, Thoren A. Fusidic acid for the treatment of antibiotic-associated colitis induced by Clostridium difficile. Infection 1984; 12:276-9.
87. Mc Farland LV, Surawicz CM, Greenberg RN, et al. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA 1994; 271: 1913-8.
88. Gorbach SL, Chang T, Goldin B. Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet 1987; 2:1519.
89. Colombel JF, Cortot A, Neut C, Romond C. Yogurt with Bifidobacterium longum reduces erythromycin-induced gastrointestinal effects. Lancet 1987; 2:43.
90. Gotz V, Romankiewicz JA, Moss J, Murray HW. Prophylaxis against ampicillin-associated diarrhea with a Lactobacillus preparation. Am J Hosp Pharm 1979; 36:754-7.